TapImmune, Inc. Announces $2 Million Registered Direct Offering
Wall Street Journal
In addition, the Company will issue to the investor warrants to purchase up to 1,886,793 shares of common stock. The warrants have an exercise price of $1.17 per share and are exercisable for five years following issuance. The offering is expected to …
After subscribing to the service (All Levels) this menu will become active to direct you to member database locations and weekly audio recordings. Please refresh the page if you have subscribed and are still seeing this message.